Fast Five Quiz: Idiopathic Pulmonary Fibrosis Treatment

Guy W. Soo Hoo, MD, MPH; Zab Mosenifar, MD


December 13, 2022

Idiopathic pulmonary fibrosis (IPF) is the most common interstitial lung disease among middle-aged and elderly adults. Although the cause of IPF is unknown, factors thought to increase an individual's risk of developing IPF include a history of smoking, gastroesophageal reflux disease, environmental exposures, and genetic predispositions. Patients with IPF typically present with fatigue, dry cough, and progressive respiratory distress of more than 6 months. The clinical course of IPF is complicated and the prognosis is poor, with a median survival of 3-5 years from diagnosis. Early diagnosis of IPF and initiation of treatment are essential to improve patient outcomes.

How much do you know about IPF treatment? Test your knowledge with this quick quiz.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.